1. Home
  2. EUDA vs SGHT Comparison

EUDA vs SGHT Comparison

Compare EUDA & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$2.35

Market Cap

68.7M

Sector

Finance

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$7.91

Market Cap

193.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
SGHT
Founded
2021
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.7M
193.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EUDA
SGHT
Price
$2.35
$7.91
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$7.66
AVG Volume (30 Days)
656.7K
290.4K
Earning Date
12-19-2023
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$5,160,280.00
$76,052,000.00
Revenue This Year
$137.25
N/A
Revenue Next Year
$361.43
$12.07
P/E Ratio
$321.86
N/A
Revenue Growth
83.73
N/A
52 Week Low
$1.03
$2.03
52 Week High
$4.70
$9.24

Technical Indicators

Market Signals
Indicator
EUDA
SGHT
Relative Strength Index (RSI) 47.73 48.85
Support Level $1.21 $7.70
Resistance Level $2.70 $9.24
Average True Range (ATR) 0.51 0.56
MACD 0.00 -0.14
Stochastic Oscillator 64.00 14.32

Price Performance

Historical Comparison
EUDA
SGHT

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Share on Social Networks: